Antibiotic Drug Articles & Analysis
9 news found
Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is ...
And it is used parenterally and short-term to relieve symptoms of osteoarthritis.D-Glucosamines for Research Use?As a drug delivery company that specializes in a range of formulation and drug delivery technologies, CD Bioparticles now offers a series of D-Glucosamines for research uses, such as CInd™ D-Glucosamine Hydrochloride, CInd™ D-Glucosamine Sulfate·2KCl, ...
The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance. ...
Michael Niederman, a leading expert in respiratory infections and a member of N8 Medical’s Scientific Advisory Board stated “Anything that can significantly reduce the presence of pathogens on the surface of an endotracheal tube is a welcome advance that has the potential to reduce a patient’s length of stay, reduce antibiotic and drug use and ...
CARB-X is awarding Vaxdyn, based in Seville, Spain, up to US$892,000, plus an additional $6.36 million if certain project milestones are met, to develop a new vaccine to prevent life-threatening drug-resistant infections, including pneumonia. Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of ...
Once identified, the tech developed a resistance profile of the patient’s infection, which told doctors what drugs would work most effectively for each patient. Other than helping patients get the correct treatment more quickly, the technology can also help the medical field reduce the over-prescription of broad-spectrum antibiotics, the study’s ...
Although they may be a common part of the bacterial mix that is often found in and on parts of the human body, they can however, sometimes cause serious infections. Vancomycin is an antibiotic that is used to treat some drug-resistant infections caused by Enterococci. In some instances, Enterococci have become resistant to this drug and are ...
These bacteria can sometimes cause infections. Vancomycin is an antibiotic that is used to treat some drug-resistant infections caused by enterococci. In some instances, enterococci have become resistant to this drug and thus are called vancomycin-resistant enterococci (VRE). Most VRE infections occur in ...
Disease emergence also occurs in developed nations due to antibiotic multi-drug resistance, leading to diseases such as extremely drug-resistant TB (XDR TB) and also from centralized food processing, and other technologies. ...